Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Esophageal DiseasesGastrointestinal DiseasesDisorder of the Genitourinary SystemGynecologic DiseasesKidney DiseasesLiver DiseasesPancreatic DiseasesProstate CancerSpinal Disease
Interventions
DEVICE

Vigileo Monitor

Study Group = The monitor and routine vital sign measurements will be used to decide how much fluid to give during surgery; Control Group = Information from the monitor will be collected and compared to the information collected from participants in Study Group.

DEVICE

FloTrac Sensor

Device connected to the patient's arterial line and Vigileo monitor that measures fluid requirements during surgery.

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Edwards Lifesciences

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER